Delivery Order SPE2DB22D2103-SPE2DB25FR9RU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a contract ceiling value of $2,211.60. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 50 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $1,124.61. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units). The contract, which is not set-aside and was competitively awarded, calls for performance completion by August 18, 2025, with fulfillment at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,819.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside contract, with an ultimate completion date of August 14, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9RUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) at a firm fixed price of $4,365.84. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreement with DLA Troop Support Medical. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.999 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, utilizes this IDC to supply an extensive range of medications, medical supplies, and specialized healthcare commodities to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. Januvia, a diabetes management medication, is among the therapeutic categories the contractor routinely provides under its federal medical procurement portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/18/25 |